INSIGHT PROVIDER
Top Quartile
Xinyao (Criss) Wang

Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)

1.5k
Insights
861.1k
Views
605
Followers
China Health Care Equity Bottom-Up Thematic (Sector/Industry)

Top Sectors

Health Care
83%
Consumer Discretionary
6%
Consumer Staples
5%
Information Technology
2%
Industrials
2%
Materials
1%
Financials
1%
Communication Services
0%
Energy
0%
Real Estate
0%

Top Verticals

Equity Bottom-Up
44%
Equity Capital Markets
39%
Thematic (Sector/Industry)
17%

Top Entities

Innovent Biologics
216
BeOne Medicines
202
Jiangsu Hengrui Medicine
175
Akeso
116
Junshi Biosciences
99
WuXi AppTec
96
Wuxi Biologics
87
JD Health
83
RemeGen
80
Sino Biopharmaceutical
78

Top Countries

China
58.5%
Hong Kong
36.8%
United States
3%
Singapore
0.4%
Russia
0.2%
India
0.2%
Japan
0.2%
United Arab Emirates
0.2%
Saudi Arabia
0.1%
Germany
0.1%
x